Jianfeng Yu

Jianfeng Yu

Auto-generated profile, based on publicly available information

Jianfeng Yu

Center for Translational Medicine, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou Medical College of Soochow University, Suzhou, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2026 in Cancer Research
Verified
Journal Article
Open access
JYJianfeng Yu
Jianfeng Yu
JZJieru Zhang
Jieru Zhang
JZJun Zhang
Jun Zhang
ZBZhenqi Bai
Zhenqi Bai
YZYunqing Zhang
Yunqing Zhang
DLDawei Li
Dawei Li
Although non–small cell lung cancer (NSCLC) is among the most prevalent malignancies, currently available treatments remain largely ineffective, highlighting the need to elucidate the precise mechanisms of tumorigenesis. The Mpr1/Pad1 N-terminal domain-containing protein (MPND) is a member of the JAMM family of deubiquitinases. In this study, we found that MPND is frequently deleted, and its expression is significantly downregulated in NSCLC tumor tissues. Low MPND levels correlated with poor clinical outcomes, and depletion of MPND enhanced cell migration, invasion, and cancer stem cell–like characteristics in NSCLC cells. Mechanistically, MPND interacted with histones, removing the ubiquitin moiety from monoubiquitinated histone H2A K119 and H2B K120 (H2B K120ub). Loss of MPND elevated the ubiquitination marks, leading to alterations in chromatin architecture. Furthermore, MPND modulated gene transcription, and its depletion activated the transforming growth factor-beta (TGFβ)/SMAD3 signaling pathway. Specifically, the knockout of MPND increased H2B K120ub and chromatin accessibility at the SMAD3 locus, facilitating transcriptional activation. In mouse tumor models and clinical samples from patients with NSCLC, the loss of MPND consistently triggered activation of the TGFβ/SMAD3 axis, thereby promoting tumor growth and metastasis. Together, these data reveal an epigenetic pathway underlying NSCLC progression and suggest that targeting the TGFβ/SMAD3 axis may be particularly effective for the treatment of MPND-deficient NSCLC tumors. Significance: Loss of MPND in lung cancer promotes tumor growth and metastasis by increasing histone ubiquitination to epigenetically activate TGFβ/SMAD3 signaling, suggesting that targeting this axis may provide therapeutic benefit in MPND-deficient tumors.

4 August 2026
Verified
Other
Open access
JYJianfeng Yu
Jianfeng Yu
JZJieru Zhang
Jieru Zhang
JZJun Zhang
Jun Zhang
ZBZhenqi Bai
Zhenqi Bai
YZYunqing Zhang
Yunqing Zhang
DLDawei Li
Dawei Li
Overexpression of MPND inhibits migration and invasion of H226 cells

4 August 2026
Verified
Other
Open access
JYJianfeng Yu
Jianfeng Yu
JZJieru Zhang
Jieru Zhang
JZJun Zhang
Jun Zhang
ZBZhenqi Bai
Zhenqi Bai
YZYunqing Zhang
Yunqing Zhang
DLDawei Li
Dawei Li
Identification of DUBs associated with OS in LUAD patients

4 August 2026
Verified
Other
Open access
JYJianfeng Yu
Jianfeng Yu
JZJieru Zhang
Jieru Zhang
JZJun Zhang
Jun Zhang
ZBZhenqi Bai
Zhenqi Bai
YZYunqing Zhang
Yunqing Zhang
DLDawei Li
Dawei Li
Lung metastasis assays of parental, FH-MPND overexpressing, and FH-MPND Mut overexpressing H226 tumor cells by tail vein injection of tumor cells into NOD/SCID mice

4 August 2026
Verified
Other
Open access
JYJianfeng Yu
Jianfeng Yu
JZJieru Zhang
Jieru Zhang
JZJun Zhang
Jun Zhang
ZBZhenqi Bai
Zhenqi Bai
YZYunqing Zhang
Yunqing Zhang
DLDawei Li
Dawei Li
Tumor growth of parental and MPND-knockout H1299 cells in nude mice

4 August 2026
Verified
Other
Open access
JYJianfeng Yu
Jianfeng Yu
JZJieru Zhang
Jieru Zhang
JZJun Zhang
Jun Zhang
ZBZhenqi Bai
Zhenqi Bai
YZYunqing Zhang
Yunqing Zhang
DLDawei Li
Dawei Li
Deubiquitination activities of the indicated DUBs on histone H2A K119ub and H2B K120ub